PharmacoEconomics View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1992

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

https://link.springer.com/journal/40273

Recent publications latest 20 shown

  • 2022-07-30 A Comparison of the Content and Consistency of Methodological Quality and Transferability Checklists for Reviewing Model-Based Economic Evaluations
  • 2022-07-30 Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network
  • 2022-07-26 Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA
  • 2022-07-25 Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience
  • 2022-07-15 Best–Worst Scaling and the Prioritization of Objects in Health: A Systematic Review
  • 2022-07-13 A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets
  • 2022-07-12 Carers’ Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations
  • 2022-07-07 Correction to: Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease
  • 2022-07-05 The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
  • 2022-07-02 Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
  • 2022-06-30 Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe Obesity
  • 2022-06-29 The Opportunity of Point-of-Care Diagnostics in General Practice: Modelling the Effects on Antimicrobial Resistance
  • 2022-06-29 Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
  • 2022-06-27 Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia
  • 2022-06-20 Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease
  • 2022-06-17 Risk-Adjusted Performance Measures: A Comment on Elbasha
  • 2022-06-17 Authors’ Reply to Comment on “Risk-Adjusted Performance Measures”
  • 2022-06-15 Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study
  • 2022-06-13 Cost-Effectiveness Analysis of Venetoclax in Combination with Azacitidine Versus Azacitidine Monotherapy in Patients with Acute Myeloid Leukemia Who are Ineligible for Intensive Chemotherapy: From a US Third Party Payer Perspective
  • 2022-06-13 Considerations Around Coding the Membership Probability Function in a Latent Class Analysis: Renewed Insights
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.8220000267028809", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "1.809000015258789", 
            "type": "Rating"
          }
        ], 
        "description": "

    PharmacoEconomics is the benchmark journal for peer-reviewed, authoritative articles on the practical application of health economics and outcomes research to optimize healthcare resource allocation. An essential resource for clinicians, those involved in health technology assessment and other professionals involved with healthcare resource allocation, budgeting and prescribing decisions.

    \n\n

    PharmacoEconomics is dedicated to the clear communication of complex pharmacoeconomic issues related to all healthcare interventions (drugs, diagnostics, devices, personalized medicine and surgical interventions).

    \n\n

    As a hybrid journal, PharmacoEconomics does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘Learn about publishing Open Access with us’ link below.

    \n\n

    PharmacoEconomics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

    \n", "editor": [ { "familyName": "Carswell", "givenName": "Christopher I.", "type": "Person" } ], "id": "sg:journal.1102812", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "1170-7690", "1179-2027" ], "license": "Hybrid", "name": "PharmacoEconomics", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "102812" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "9212404" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "445705" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "14835" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1102812" ], "sdDataset": "journals", "sdDatePublished": "2022-08-04T17:25", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/journal/journal_0.jsonl", "startYear": "1992", "type": "Periodical", "url": "https://link.springer.com/journal/40273" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1102812'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1102812'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1102812'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1102812'


     

    This table displays all metadata directly associated to this object as RDF triples.

    56 TRIPLES      20 PREDICATES      26 URIs      22 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1102812 schema:contentRating N227da545143143258ce6e0e6ca31f898
    2 N7279a27747a3454fb6ed929978bff554
    3 schema:description <p><em>PharmacoEconomics</em>&nbsp;is the benchmark journal for peer-reviewed, authoritative articles on the practical application of health economics and outcomes research to optimize healthcare resource allocation. An essential resource for clinicians, those involved in health technology assessment and other professionals involved with healthcare resource allocation, budgeting and prescribing decisions.</p> <p><em>PharmacoEconomics</em>&nbsp;is dedicated to the clear communication of complex pharmacoeconomic issues related to all healthcare interventions (drugs, diagnostics, devices, personalized medicine and surgical interventions).</p> <p>As a hybrid journal, <em>PharmacoEconomics</em> does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice&trade; initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the &lsquo;Learn about publishing Open Access with us&rsquo; link below.</p> <p><em>PharmacoEconomics </em>offers a range of additional features designed to increase the visibility, readership and educational value of the journal&rsquo;s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager&reg;, supported by a database of international experts. This database is shared with other Adis journals.</p>
    4 schema:editor N2e0dca51247342b88e8e6ac932d92774
    5 schema:inLanguage en
    6 schema:isAccessibleForFree false
    7 schema:issn 1170-7690
    8 1179-2027
    9 schema:license Hybrid
    10 schema:name PharmacoEconomics
    11 schema:productId N0629a116b96a49d293997395d2dd26ad
    12 N32607c92d742484c88b1111e2a8c9253
    13 N8ff4793a512c4cc0baa1141f1cd3aef5
    14 Ndf858137c468494fbd15f2d401b370ff
    15 schema:publisher Nf658ec6c178346ccb923b470ae99dbd0
    16 schema:publisherImprint Adis
    17 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1102812
    18 schema:sdDatePublished 2022-08-04T17:25
    19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    20 schema:sdPublisher Ne24be79e661b49d0816eb9b995590dd9
    21 schema:startYear 1992
    22 schema:url https://link.springer.com/journal/40273
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset journals
    25 rdf:type schema:Periodical
    26 N0629a116b96a49d293997395d2dd26ad schema:name nsd_ids_id
    27 schema:value 445705
    28 rdf:type schema:PropertyValue
    29 N227da545143143258ce6e0e6ca31f898 schema:author N22d245c316594911ab1549618d1b17ab
    30 schema:ratingValue 1.809000015258789
    31 rdf:type schema:Rating
    32 N22d245c316594911ab1549618d1b17ab rdf:first sjr
    33 rdf:rest rdf:nil
    34 N2e0dca51247342b88e8e6ac932d92774 rdf:first N82d13f24208c4b2fbbc7eae2d18a7fa9
    35 rdf:rest rdf:nil
    36 N32607c92d742484c88b1111e2a8c9253 schema:name nlm_unique_id
    37 schema:value 9212404
    38 rdf:type schema:PropertyValue
    39 N7279a27747a3454fb6ed929978bff554 schema:author N760f2160d2494b93853e648d2a54be1e
    40 schema:ratingValue 1.8220000267028809
    41 rdf:type schema:Rating
    42 N760f2160d2494b93853e648d2a54be1e rdf:first snip
    43 rdf:rest rdf:nil
    44 N82d13f24208c4b2fbbc7eae2d18a7fa9 schema:familyName Carswell
    45 schema:givenName Christopher I.
    46 rdf:type schema:Person
    47 N8ff4793a512c4cc0baa1141f1cd3aef5 schema:name dimensions_id
    48 schema:value 102812
    49 rdf:type schema:PropertyValue
    50 Ndf858137c468494fbd15f2d401b370ff schema:name era_ids_id
    51 schema:value 14835
    52 rdf:type schema:PropertyValue
    53 Ne24be79e661b49d0816eb9b995590dd9 schema:name Springer Nature - SN SciGraph project
    54 rdf:type schema:Organization
    55 Nf658ec6c178346ccb923b470ae99dbd0 schema:name Springer International Publishing
    56 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...